Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05712473
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-03
First Post:
2023-01-25
Brief Title:
An Observational Registry Assessing the Impact of PYLARIFY Piflufolastat F18 PET in Patients With Prostate Cancer
Sponsor:
PPsanalytics
Organization:
PPsanalytics
Study Overview
Official Title:
A Prospective Observational Multicenter Real-World Registry Assessing the Impact of the Use of PYLARIFY Piflufolastat F18 PET in Patients With Prostate Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational research is to assess the real-world clinical utility of PYLARIFY PET through evaluation of long-term outcomes for prostate cancer patients who are eligible for a PSMAPET scan
Participants will be enrolled at their physicians office at the time of referral for PYLARIFY PET and will be followed for up to 5 years Data concerning their prostate cancer diagnostics and treatment will be collected at 6-month intervals
Participants will be enrolled at their physicians office at the time of referral for PYLARIFY PET and will be followed for up to 5 years Data concerning their prostate cancer diagnostics and treatment will be collected at 6-month intervals
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None